Schonfeld Strategic Advisors LLC Invests $1.86 Million in Clover Health Investments, Corp. (NASDAQ:CLOV)

Schonfeld Strategic Advisors LLC bought a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 590,571 shares of the company's stock, valued at approximately $1,860,000. Schonfeld Strategic Advisors LLC owned 0.12% of Clover Health Investments as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in CLOV. Barclays PLC purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at $298,000. Virtu Financial LLC lifted its position in shares of Clover Health Investments by 344.5% during the third quarter. Virtu Financial LLC now owns 58,518 shares of the company's stock worth $165,000 after purchasing an additional 45,354 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Clover Health Investments during the third quarter worth about $105,000. JPMorgan Chase & Co. purchased a new position in shares of Clover Health Investments in the third quarter valued at approximately $448,000. Finally, Silverleafe Capital Partners LLC grew its holdings in shares of Clover Health Investments by 182.9% in the fourth quarter. Silverleafe Capital Partners LLC now owns 45,000 shares of the company's stock valued at $142,000 after purchasing an additional 29,091 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Stock Performance

CLOV stock traded down $0.24 during mid-day trading on Friday, reaching $3.51. The company had a trading volume of 7,646,927 shares, compared to its average volume of 6,801,763. The firm has a fifty day simple moving average of $3.57 and a 200 day simple moving average of $3.71. The company has a market capitalization of $1.79 billion, a price-to-earnings ratio of -17.55 and a beta of 1.99. Clover Health Investments, Corp. has a fifty-two week low of $0.79 and a fifty-two week high of $4.87.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.12. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The company had revenue of $462.33 million during the quarter, compared to the consensus estimate of $466.93 million. As a group, analysts predict that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Carladenise Armbrister Edwards sold 200,000 shares of the company's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $3.61, for a total value of $722,000.00. Following the completion of the transaction, the director now owns 273,227 shares in the company, valued at approximately $986,349.47. This represents a 42.26 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Brady Patrick Priest sold 75,000 shares of the firm's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $3.68, for a total value of $276,000.00. Following the transaction, the chief executive officer now directly owns 2,418,151 shares in the company, valued at approximately $8,898,795.68. The trade was a 3.01 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 327,500 shares of company stock worth $1,197,500. Corporate insiders own 22.28% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a report on Monday, March 3rd.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.